2020 Program Announcements (PAs) | |
PA No. and Title | Status - Expiration |
---|---|
PAR20-314 Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) | ACTIVE - OCT 11, 2023 |
PAR20-313 Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) | ACTIVE - OCT 11, 2023 |
PAR20-305 Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, and 2023 (P50 Clinical Trial Required) | ACTIVE - JAN 08, 2024 |
PAR20-303 Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional) | EXPIRED - SEP 08, 2023 |
PAR20-302 Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional) | EXPIRED - SEP 08, 2023 |